Question

I am a breastfeeding mother and i want to know if it is safe to use Cemiplimab? Is Cemiplimab safe for nursing mother and child? Does Cemiplimab extracts into breast milk? Does Cemiplimab has any long term or short term side effects on infants? Can Cemiplimab influence milk supply or can Cemiplimab decrease milk supply in lactating mothers?

Answer by DrLact: About Cemiplimab usage in lactation

No information is available on the clinical use of cemiplimab during breastfeeding. Because cemiplimab is a large protein molecule with a molecular weight of about 146,000, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. The manufacturer recommends that breastfeeding be discontinued during cemiplimab therapy and for 4 months after the last dose. Cemiplimab is a human immunoglobulin G4 (IgG4) antibody. Holder pasteurization (62.5 degrees C for 30 minutes) decreases the concentration of endogenous immunoglobulin G by up to 79%.[1][2] A study of 67 colostrum samples that underwent Holder pasteurization found that IgG amounts decreased by 34 to 40%. Specific IgG subclasses decreased by different amounts, with Holder pasteurization having little effect on IgG4 activity.[3] None of the studies measured IgG activity.

Alternate Drugs

Trastuzumab(Unsafe)
Secukinumab(Low Risk)
Cetuximab(Unsafe)
Nivolumab(Unsafe)
Ustekinumab(Low Risk)
Denosumab(Low Risk)
Omalizumab(Low Risk)
Ipilimumab(Unsafe)
Rituximab(Low Risk)
Abciximab(Low Risk)
Bevacizumab(Low Risk)
Basiliximab(Low Risk)
Belimumab(Low Risk)
Natalizumab(Low Risk)
Cyclophosphamide(Dangerous)
Trastuzumab(Unsafe)
Cisplatin(Unsafe)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Paclitaxel(Dangerous)
Vinblastine(Dangerous)
Fluorouracil(Dangerous)
Dasatinib(Unsafe)
Vincristine(Dangerous)
Bleomycin(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Ipilimumab(Unsafe)
Tamoxifen(Dangerous)
Vinorelbine(Dangerous)
Mitoxantrone(Dangerous)
Letrozole(Dangerous)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Exemestane(Dangerous)
Docetaxel(Dangerous)
Bevacizumab(Low Risk)
Hydroxyurea(Low Risk)
Thioguanine(Dangerous)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Pazopanib(Unsafe)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.